OCC 0.65% 39.0¢ orthocell limited

From the Managing Director...., page-2

  1. 689 Posts.
    lightbulb Created with Sketch. 128
    The one interesting point to observe in the ARGONAUT report is:

    "More results are pending: The study involves 20 patients, and 15 of the 20 have been treated. Recruitment is expected to be completed in Q2 CY2019. These results are from the first four patients in the study, and we can expect further results over the coming months. Testing of the patient responses was carried out using the British Medical Research Council Grading System. The study is being undertaken at the St John of God Subiaco Hospital in Perth under the guidance of Dr Alex O’Beirne and Professor Ming Hao Zheng of UWA."

    If the next report is as promising as the first four patients, then there could be another rerating.

    Of course, this is just my opinion!


    Last edited by dingledongle: 10/05/19
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
0.003(0.65%)
Mkt cap ! $81.63M
Open High Low Value Volume
39.0¢ 39.5¢ 38.5¢ $81.85K 212.3K

Buyers (Bids)

No. Vol. Price($)
3 26432 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 16642 2
View Market Depth
Last trade - 15.40pm 29/03/2024 (20 minute delay) ?
Last
39.5¢
  Change
0.003 ( 2.60 %)
Open High Low Volume
40.0¢ 40.0¢ 38.5¢ 79914
Last updated 15.32pm 29/03/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.